Ormat Technologies, Inc.
Ormat Technologies, Inc. (ORA) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Ormat Technologies, Inc. (ORA), featuring income statements, balance sheets, and cash flow data.
Ormat Technologies, Inc. (ORA) Income Statement & Financial Overview
Review Ormat Technologies, Inc. ORA income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $229.76M | $230.74M | $211.78M | $212.96M |
Cost of Revenue | $156.84M | $157.18M | $152.92M | $151.58M |
Gross Profit | $72.93M | $73.56M | $58.86M | $61.39M |
Gross Profit Ratio | $0.32 | $0.32 | $0.28 | $0.29 |
R&D Expenses | $2.54M | $1.39M | $1.82M | $1.73M |
SG&A Expenses | $22.08M | $23.74M | $27.22M | $22.19M |
Operating Expenses | $22.01M | $24.48M | $23.19M | $23.92M |
Total Costs & Expenses | $178.85M | $189.46M | $176.11M | $175.50M |
Interest Income | $1.31M | $1.39M | $2.05M | $2.60M |
Interest Expense | $34.47M | $34.52M | $34.82M | $33.72M |
Depreciation & Amortization | $69.78M | $70.05M | $132.47M | $65.79M |
EBITDA | $141.86M | $135.35M | $126.22M | $101.87M |
EBITDA Ratio | $0.62 | $0.59 | $0.60 | $0.48 |
Operating Income | $50.91M | $49.09M | -$6.25M | $37.46M |
Operating Income Ratio | $0.22 | $0.21 | -$0.03 | $0.18 |
Other Income/Expenses (Net) | -$13.31M | -$17.37M | $30.98M | -$15.57M |
Income Before Tax | $37.61M | $31.72M | $24.73M | $19.55M |
Income Before Tax Ratio | $0.16 | $0.14 | $0.12 | $0.09 |
Income Tax Expense | -$3.79M | -$11.77M | $1.19M | -$3.18M |
Net Income | $40.36M | $40.82M | $22.08M | $22.24M |
Net Income Ratio | $0.18 | $0.18 | $0.10 | $0.10 |
EPS | $0.67 | $0.67 | $0.37 | $0.37 |
Diluted EPS | $0.66 | $0.67 | $0.36 | $0.37 |
Weighted Avg Shares Outstanding | $60.56M | $60.48M | $60.48M | $60.45M |
Weighted Avg Shares Outstanding (Diluted) | $60.84M | $60.77M | $60.77M | $60.76M |
The company's financials show resilient growth, with revenue advancing from $212.96M in Q2 2024 to $229.76M in Q1 2025. Gross profit remained healthy with margins at 32% in Q1 2025 compared to 29% in Q2 2024. Operating income hit $50.91M last quarter, sustaining a consistent 22% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $141.86M. Net income dropped to $40.36M, while earnings per share reached $0.67. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan